These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 15824083)

  • 1. Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma.
    Rousseaux C; Lefebvre B; Dubuquoy L; Lefebvre P; Romano O; Auwerx J; Metzger D; Wahli W; Desvergne B; Naccari GC; Chavatte P; Farce A; Bulois P; Cortot A; Colombel JF; Desreumaux P
    J Exp Med; 2005 Apr; 201(8):1205-15. PubMed ID: 15824083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of peroxisome proliferation-activated receptor gamma expression by gamma-irradiation as a mechanism contributing to inflammatory response in rat colon: modulation by the 5-aminosalicylic acid agonist.
    Linard C; Grémy O; Benderitter M
    J Pharmacol Exp Ther; 2008 Mar; 324(3):911-20. PubMed ID: 18077625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Aminosalicylic Acid Ameliorates Colitis and Checks Dysbiotic Escherichia coli Expansion by Activating PPAR-γ Signaling in the Intestinal Epithelium.
    Cevallos SA; Lee JY; Velazquez EM; Foegeding NJ; Shelton CD; Tiffany CR; Parry BH; Stull-Lane AR; Olsan EE; Savage HP; Nguyen H; Ghanaat SS; Byndloss AJ; Agu IO; Tsolis RM; Byndloss MX; Bäumler AJ
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma.
    Zhang M; Deng C; Zheng J; Xia J; Sheng D
    Int Immunopharmacol; 2006 Aug; 6(8):1233-42. PubMed ID: 16782535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model.
    Ikeda I; Tomimoto A; Wada K; Fujisawa T; Fujita K; Yonemitsu K; Nozaki Y; Endo H; Takahashi H; Yoneda M; Inamori M; Kubota K; Saito S; Nagashima Y; Nakagama H; Nakajima A
    Clin Cancer Res; 2007 Nov; 13(21):6527-31. PubMed ID: 17975166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunct therapy of n-3 fatty acids to 5-ASA ameliorates inflammatory score and decreases NF-κB in rats with TNBS-induced colitis.
    Mbodji K; Charpentier C; Guérin C; Querec C; Bole-Feysot C; Aziz M; Savoye G; Déchelotte P; Marion-Letellier R
    J Nutr Biochem; 2013 Apr; 24(4):700-5. PubMed ID: 22841543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence.
    Desreumaux P; Ghosh S
    Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 1():2-9. PubMed ID: 16939423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactobacillus crispatus M247-derived H2O2 acts as a signal transducing molecule activating peroxisome proliferator activated receptor-gamma in the intestinal mucosa.
    Voltan S; Martines D; Elli M; Brun P; Longo S; Porzionato A; Macchi V; D'Incà R; Scarpa M; Palù G; Sturniolo GC; Morelli L; Castagliuolo I
    Gastroenterology; 2008 Oct; 135(4):1216-27. PubMed ID: 18722375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity.
    Berruyer C; Pouyet L; Millet V; Martin FM; LeGoffic A; Canonici A; Garcia S; Bagnis C; Naquet P; Galland F
    J Exp Med; 2006 Dec; 203(13):2817-27. PubMed ID: 17145956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic analysis of sulfasalazine effect in experimental colitis is consistent primarily with the modulation of NF-kappaB but not PPAR-gamma signaling.
    Martínez-Augustin O; López-Posadas R; González R; Suárez MD; Zarzuelo A; Sánchez de Medina F
    Pharmacogenet Genomics; 2009 May; 19(5):363-72. PubMed ID: 19365232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant properties of mesalamine in colitis inhibit phosphoinositide 3-kinase signaling in progenitor cells.
    Managlia E; Katzman RB; Brown JB; Barrett TA
    Inflamm Bowel Dis; 2013 Sep; 19(10):2051-60. PubMed ID: 23867870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
    Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
    Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy.
    Karrout Y; Dubuquoy L; Piveteau C; Siepmann F; Moussa E; Wils D; Beghyn T; Neut C; Flament MP; Guerin-Deremaux L; Dubreuil L; Deprez B; Desreumaux P; Siepmann J
    J Control Release; 2015 Jan; 197():121-30. PubMed ID: 25445696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
    Celinski K; Dworzanski T; Korolczuk A; Piasecki R; Slomka M; Madro A; Fornal R
    J Physiol Pharmacol; 2011 Jun; 62(3):347-56. PubMed ID: 21893696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An anti-inflammatory mechanism of taurine conjugated 5-aminosalicylic acid against experimental colitis: taurine chloramine potentiates inhibitory effect of 5-aminosalicylic acid on IL-1beta-mediated NFkappaB activation.
    Joo K; Lee Y; Choi D; Han J; Hong S; Kim YM; Jung Y
    Eur J Pharmacol; 2009 Sep; 618(1-3):91-7. PubMed ID: 19616541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Hydroxydocosahexaenoic acid, a potent peroxisome proliferator-activated receptor gamma agonist alleviates the symptoms of DSS-induced colitis.
    Yamamoto K; Ninomiya Y; Iseki M; Nakachi Y; Kanesaki-Yatsuka Y; Yamanoue Y; Itoh T; Nishii Y; Petrovsky N; Okazaki Y
    Biochem Biophys Res Commun; 2008 Mar; 367(3):566-72. PubMed ID: 18191038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis.
    Fiorucci S; Orlandi S; Mencarelli A; Caliendo G; Santagada V; Distrutti E; Santucci L; Cirino G; Wallace JL
    Br J Pharmacol; 2007 Apr; 150(8):996-1002. PubMed ID: 17339831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARgamma as a new therapeutic target in inflammatory bowel diseases.
    Dubuquoy L; Rousseaux C; Thuru X; Peyrin-Biroulet L; Romano O; Chavatte P; Chamaillard M; Desreumaux P
    Gut; 2006 Sep; 55(9):1341-9. PubMed ID: 16905700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular mechanism for the anti-inflammatory effect of taurine-conjugated 5-aminosalicylic acid in inflamed colon.
    Kim H; Jeon H; Kong H; Yang Y; Choi B; Kim YM; Neckers L; Jung Y
    Mol Pharmacol; 2006 Apr; 69(4):1405-12. PubMed ID: 16407467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dexamethasone on peroxisome proliferator activated receptor-gamma mRNA expression in 3T3-L1 adipocytes with the human recombinant adiponectin.
    She QM; Zhao J; Wang XL; Zhou CM; Shi XZ
    Chin Med J (Engl); 2007 Jan; 120(2):155-8. PubMed ID: 17335662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.